Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
基本信息
- 批准号:10434100
- 负责人:
- 金额:$ 35.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Automobile DrivingBRAT geneBehaviorBiologicalBiologyBrain NeoplasmsCDK5 geneCXCR4 geneCell divisionCellsDataDaughterDevelopmentDrosophila genusDyesEquilibriumGene TargetingGenesGeneticGenetically Engineered MouseGlioblastomaGliomaGoalsGrowthHumanHypoxiaIn VitroLasersLeadMalignant - descriptorMalignant GliomaMalignant neoplasm of brainMicroscopicMolecularMusMutateNecrosisNecrosis InductionNeoplasmsNervous system structureOrthologous GenePathway interactionsPatternPharmacologyPhenotypePrimary Brain NeoplasmsProcessPrognosisPropertyRecurrenceRose BengalSelf-DirectionSignal TransductionStudy modelsSystemTechniquesTherapeuticThrombosisTimeTumor Stem CellsTumor Suppressor ProteinsTumorigenicityUp-RegulationWorkXenograft ModelXenograft procedurecraniumdaughter cellhuman modelin vivoin vivo Modelinhibitormigrationmouse modelmultiphoton microscopyneoplasticneoplastic cellnestin proteinneuroblastnovelnovel therapeuticsphotoactivationpluripotencypre-clinicalprogramsresponseself-renewalstemstem cell expansionstem cell functionstem cellsstemnesstargeted treatmenttherapeutic targettherapy resistanttreatment strategytumor growthtumor microenvironment
项目摘要
Project Summary/Abstract
Glioblastoma (GBM) is the most common and most malignant primary brain tumor and
has a dismal prognosis. Abundant evidence now indicates that a small subset of
neoplastic cells, referred to as Glioma Stem Cells (GSCs), governs biologic behavior
and resistance to therapy. GSCs inhabit specific biologic niches and have properties of
self-renewal, pluripotency and high tumorigenicity. They can be identified by expression
of markers, such as CD133, CD15 and nestin, yet molecular mechanisms responsible
for their specific stem-like behavior in glioblastomas have not been fully defined. This
proposal aims to define mechanisms underlying fundamental biological properties of
GSCs, including: 1) their marked accumulation following the development of necrosis
and tendency to localize to the hypoxic niche; and 2) a disrupted program of asymmetric
cell division that favors self-renewing division over differentiation. We have developed
novel in vitro and in vivo models and analytic techniques to study the differential
behavior of stem and non-stem glioma cells within the tumor micro-environment,
especially as it relates to their accumulation in regions of hypoxia. These include an in
vivo orthotopic xenograft model in which stem cells are interrogated for patterns and
mechanisms of accumulation following the induction of necrosis using a photo-activated
dye. We also dissect pathways that direct asymmetric cellular division in Drosophila
nervous system provide clues to understand the stem/non-stem dynamics in malignant
gliomas. We have previously demonstrated that the human ortholog of Drosophila Brat,
Trim3, is a tumor suppressor that regulates glioma stem cell dynamics and promotes
stemness when lost. Here we propose to investigate novel regulatory mechanisms that
arise during transition to the stem cell phenotype that can be antagonized
therapeutically. Regulatory networks and potential therapeutic targets are further
explored in xenografts and genetically engineered mouse models that recapitulates
human gliomas to show efficacy.
项目总结/文摘
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
- DOI:10.1007/s00401-020-02127-9
- 发表时间:2020-03
- 期刊:
- 影响因子:12.7
- 作者:Brat DJ;Aldape K;Colman H;Figrarella-Branger D;Fuller GN;Giannini C;Holland EC;Jenkins RB;Kleinschmidt-DeMasters B;Komori T;Kros JM;Louis DN;McLean C;Perry A;Reifenberger G;Sarkar C;Stupp R;van den Bent MJ;von Deimling A;Weller M
- 通讯作者:Weller M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL J BRAT其他文献
DANIEL J BRAT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL J BRAT', 18)}}的其他基金
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
模拟胶质母细胞瘤微环境以揭示进展机制和治疗靶点
- 批准号:
10394722 - 财政年份:2020
- 资助金额:
$ 35.57万 - 项目类别:
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
模拟胶质母细胞瘤微环境以揭示进展机制和治疗靶点
- 批准号:
10611990 - 财政年份:2020
- 资助金额:
$ 35.57万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
9756347 - 财政年份:2018
- 资助金额:
$ 35.57万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
9978761 - 财政年份:2018
- 资助金额:
$ 35.57万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
10212336 - 财政年份:2018
- 资助金额:
$ 35.57万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
8675210 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
9634560 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
9063107 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
8502036 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:














{{item.name}}会员




